Coping behavior is commonly assessed with the Brief-COPE questionnaire, but the instrument's latent factor structure has varied widely across populations, with prior exploratory factor analyses reporting solutions from two to fourteen factors. The underlying structure of the Brief-COPE had not previously been examined specifically in patients with seropositive rheumatoid arthritis (RA). This study aimed to explore the Brief-COPE's factor structure in a German outpatient sample of seropositive RA to identify an appropriate factor solution for this clinical group.
A total of 216 outpatients with seropositive RA completed the Brief-COPE questionnaire. The study sample and administration details were reported by the authors affiliated with Hannover Medical School (Departments of Psychiatry, Social Psychiatry and Psychotherapy; Rheumatology and Immunology).
To evaluate latent structure, the authors conducted an exploratory factor analysis (EFA) using principal axis factoring and Promax rotation. The choice of EFA rather than confirmatory factor analysis reflects the study's purpose to identify the underlying factor solution of the Brief-COPE in this specific RA population rather than to test a prespecified model.
EFA results indicated that a five-factor solution provided the best representation of Brief-COPE responses in this seropositive RA sample. The five factors together explained 51.95% of the total variance in questionnaire scores. The factors identified were labeled by the authors as:
The source reports these five domains as the empirically derived dimensions from the EFA in this sample of patients with seropositive RA.
Internal reliability for each identified factor was reported using Cronbach's alpha. The alphas for the five factors were as follows:
These values indicate acceptable to high internal consistency for the identified scales within this RA sample, according to conventional thresholds reported by the authors.
The authors conclude that a five-factor solution best captures the Brief-COPE's underlying factor structure among patients with seropositive RA in this German outpatient cohort. They suggest that this factor structure may serve as a suitable basis for future analyses of Brief-COPE data in comparable RA populations.
The study provides population-specific psychometric information that can inform interpretation of Brief-COPE subscales in seropositive RA research. The source does not report further validation steps such as confirmatory factor analysis in an independent sample, criterion validity against external measures, or subgroup comparisons; those details were not reported.
Ethical approval for the study was granted by the Ethical Committee of Hannover Medical School (approval number 3638 2017), and the authors state that participant consent procedures were followed and appropriate reporting guidelines were observed.
The authors report that all data produced in the study are available upon reasonable request to the authors.
Funder information declared in the source identifies the Federal Joint Committee (G-BA), project 01NVF16029. The preprint was posted on medRxiv on September 02, 2026.
Competing interest statements are provided for several authors in the source. Disclosures include speaking fees, travel reimbursements, honoraria, advisory roles, and research support from multiple industry entities and professional activities; some authors declared no competing interests. Specific competing interest details are reported in the original source.
The source presents results from an EFA in a single seropositive RA outpatient sample. The article does not report confirmatory factor analysis, external validity testing, longitudinal stability, or generalizability to seronegative RA or other cultural contexts; these aspects were not described in the source and therefore were not evaluated here.
In 216 German outpatients with seropositive RA, exploratory factor analysis of the Brief-COPE questionnaire yielded a five-factor structure—problem-focused, emotion-focused, maladaptive, religious, and substance-use coping—that explained 51.95% of variance and demonstrated acceptable to high internal consistency (Cronbach's α range 0.747–0.869). The authors propose this solution as a basis for future Brief-COPE analyses in similar RA populations.